{"transactions":[{"id":1784452,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-09-08T20:44:26.000Z","date":"2023-09-06","kind":"exercise","planned":true,"acquired":false,"shares":4620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest and settle as to one third of the RSUs on each of the first three anniversaries of September 6, 2022 so that such RSUs will become fully vested on September 6, 2025. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest and settle as to one third of the RSUs on each of the first three anniversaries of September 6, 2022 so that such RSUs will become fully vested on September 6, 2025. The RSUs have no expiration date."}],"balance_after":9380,"derivative":{"underlying":"Common Stock","underlying_shares":4620},"source":{"system":"sec-edgar","filing":"0000950170-23-047302","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017023047302/ownership.xml","form_type":"4"}},{"id":1784451,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-09-08T20:44:26.000Z","date":"2023-09-06","kind":"sale","planned":true,"acquired":false,"shares":1448,"price":1.1502,"value":1665.4896,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs."}],"balance_after":150874,"source":{"system":"sec-edgar","filing":"0000950170-23-047302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017023047302/ownership.xml","form_type":"4"}},{"id":1784450,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-09-08T20:44:26.000Z","date":"2023-09-06","kind":"exercise","planned":true,"acquired":true,"shares":4620,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":152322,"source":{"system":"sec-edgar","filing":"0000950170-23-047302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017023047302/ownership.xml","form_type":"4"}},{"id":1989599,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-02-27T21:05:18.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."}],"balance_after":105000,"derivative":{"underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0000899243-23-006206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924323006206/doc4.xml","form_type":"4"}},{"id":1989598,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-02-27T21:05:18.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":632000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2023."}],"balance_after":632000,"derivative":{"exercise_price":1.6,"expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":632000},"source":{"system":"sec-edgar","filing":"0000899243-23-006206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924323006206/doc4.xml","form_type":"4"}},{"id":2056237,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-01-11T21:05:16.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":3620,"price":1.3904,"value":5033.248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $1.39 to $1.40. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2."}],"balance_after":143166,"source":{"system":"sec-edgar","filing":"0000899243-23-001575","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924323001575/doc4.xml","form_type":"4"}},{"id":2065530,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-01-04T21:35:00.000Z","date":"2023-01-01","kind":"exercise","acquired":false,"shares":6930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date."}],"balance_after":14070,"derivative":{"underlying":"Common Stock","underlying_shares":6930},"source":{"system":"sec-edgar","filing":"0000899243-23-000629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924323000629/doc4.xml","form_type":"4"}},{"id":2065529,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-01-04T21:35:00.000Z","date":"2023-01-01","kind":"exercise","acquired":false,"shares":4290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date."}],"balance_after":4420,"derivative":{"underlying":"Common Stock","underlying_shares":4290},"source":{"system":"sec-edgar","filing":"0000899243-23-000629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924323000629/doc4.xml","form_type":"4"}},{"id":2065528,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-01-04T21:35:00.000Z","date":"2023-01-01","kind":"exercise","acquired":true,"shares":6930,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":146786,"source":{"system":"sec-edgar","filing":"0000899243-23-000629","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924323000629/doc4.xml","form_type":"4"}},{"id":2065527,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-01-04T21:35:00.000Z","date":"2023-01-01","kind":"exercise","acquired":true,"shares":4290,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,920 shares acquired under Issuer's Employee Stock Purchase Plan on August 31, 2022."}],"balance_after":139856,"source":{"system":"sec-edgar","filing":"0000899243-23-000629","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924323000629/doc4.xml","form_type":"4"}},{"id":2162867,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2022-09-08T20:05:16.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of September 6, 2022 so that such RSUs will become fully vested on September 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."}],"balance_after":14000,"derivative":{"underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0000899243-22-030658","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924322030658/doc4.xml","form_type":"4"}},{"id":2162866,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-09-08T20:05:16.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following September 6, 2022."}],"balance_after":23000,"derivative":{"exercise_price":2.18,"expiration_date":"2032-09-06","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000899243-22-030658","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924322030658/doc4.xml","form_type":"4"}},{"id":2292451,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-04-21T21:31:10.000Z","date":"2022-04-21","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following April 21, 2022."}],"balance_after":60000,"derivative":{"exercise_price":1.78,"expiration_date":"2032-04-21","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-22-015323","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924322015323/doc4.xml","form_type":"4"}},{"id":2368284,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-28T21:05:20.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.  The restricted stock units have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.  The restricted stock units have no expiration date."}],"balance_after":21000,"derivative":{"underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000899243-22-008060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924322008060/doc4.xml","form_type":"4"}},{"id":2368283,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-28T21:05:20.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":128000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022."}],"balance_after":128000,"derivative":{"exercise_price":2.71,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":128000},"source":{"system":"sec-edgar","filing":"0000899243-22-008060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924322008060/doc4.xml","form_type":"4"}},{"id":2436464,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-12T21:05:30.000Z","date":"2022-01-01","kind":"exercise","acquired":false,"shares":4290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.  The RSUs do not have an expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.  The RSUs do not have an expiration date."}],"balance_after":8710,"derivative":{"underlying":"Common Stock","underlying_shares":4290},"source":{"system":"sec-edgar","filing":"0000899243-22-001746","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924322001746/doc4.xml","form_type":"4"}},{"id":2436463,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-12T21:05:30.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":1661,"price":3.7801,"value":6278.7461,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.79.  The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3."}],"balance_after":131646,"source":{"system":"sec-edgar","filing":"0000899243-22-001746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924322001746/doc4.xml","form_type":"4"}},{"id":2436462,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-12T21:05:30.000Z","date":"2022-01-01","kind":"exercise","acquired":true,"shares":4290,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":133307,"source":{"system":"sec-edgar","filing":"0000899243-22-001746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924322001746/doc4.xml","form_type":"4"}},{"id":2871139,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-09T21:25:09.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024."}],"balance_after":13000,"derivative":{"underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0000899243-21-005461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924321005461/doc4.xml","form_type":"4"}},{"id":2871138,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-09T21:25:09.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":78000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021."}],"balance_after":78000,"derivative":{"exercise_price":13.78,"expiration_date":"2031-02-05","underlying":"Common Stock","underlying_shares":78000},"source":{"system":"sec-edgar","filing":"0000899243-21-005461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924321005461/doc4.xml","form_type":"4"}},{"id":2911738,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-01-08T21:05:12.000Z","date":"2021-01-07","kind":"sale","acquired":false,"shares":5103,"price":12.0457,"value":61469.2071,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $12.00 to $12.17. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":129017,"source":{"system":"sec-edgar","filing":"0000899243-21-001153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924321001153/doc4.xml","form_type":"4"}},{"id":2911737,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-01-08T21:05:12.000Z","date":"2021-01-06","kind":"sale","acquired":false,"shares":9897,"price":12.0638,"value":119395.4286,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $12.00 to $12.21. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":134120,"source":{"system":"sec-edgar","filing":"0000899243-21-001153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924321001153/doc4.xml","form_type":"4"}},{"id":2913256,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-01-07T21:05:07.000Z","date":"2021-01-05","kind":"sale","acquired":false,"shares":10000,"price":11.4422,"value":114422.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $11.25 to $11.68. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":144017,"source":{"system":"sec-edgar","filing":"0000899243-21-000891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924321000891/doc4.xml","form_type":"4"}},{"id":3321338,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-03T22:33:38.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":9133,"price":20.4989,"value":187216.4537,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $20.4100 to $20.6800. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":154017,"source":{"system":"sec-edgar","filing":"0000899243-20-000314","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924320000314/doc4.xml","form_type":"4"}},{"id":3342006,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-13T21:06:22.000Z","date":"2019-12-11","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2020."}],"balance_after":110000,"derivative":{"exercise_price":19.92,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0000899243-19-029156","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924319029156/doc4.xml","form_type":"4"}},{"id":3353622,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-12-03T21:05:29.000Z","date":"2019-12-02","kind":"sale","acquired":false,"shares":9300,"price":16.2333,"value":150969.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $16.04 to $16.355. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":163150,"source":{"system":"sec-edgar","filing":"0000899243-19-028392","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924319028392/doc4.xml","form_type":"4"}},{"id":3353621,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-12-03T21:05:29.000Z","date":"2019-11-29","kind":"sale","acquired":false,"shares":9300,"price":16.0634,"value":149389.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $16.00 to $16.24. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":172450,"source":{"system":"sec-edgar","filing":"0000899243-19-028392","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924319028392/doc4.xml","form_type":"4"}},{"id":3400326,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-10-02T20:07:28.000Z","date":"2019-10-01","kind":"sale","acquired":false,"shares":100,"price":18.23,"value":1823.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."}],"balance_after":181750,"source":{"system":"sec-edgar","filing":"0000899243-19-024656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924319024656/doc4.xml","form_type":"4"}},{"id":3400325,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-10-02T20:07:28.000Z","date":"2019-10-01","kind":"sale","acquired":false,"shares":9200,"price":17.3844,"value":159936.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $17.09 to $17.85. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":181850,"source":{"system":"sec-edgar","filing":"0000899243-19-024656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924319024656/doc4.xml","form_type":"4"}},{"id":3421484,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-09-05T20:40:17.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":9300,"price":18.7402,"value":174283.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $18.29 to $19.06. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":191050,"source":{"system":"sec-edgar","filing":"0000899243-19-022840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924319022840/doc4.xml","form_type":"4"}},{"id":3446539,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-08-05T20:18:35.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":9300,"price":17.3681,"value":161523.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $16.87 to $17.65. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":200350,"source":{"system":"sec-edgar","filing":"0000899243-19-020993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924319020993/doc4.xml","form_type":"4"}},{"id":3467250,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-07-03T20:32:42.000Z","date":"2019-07-01","kind":"sale","acquired":false,"shares":100,"price":19.56,"value":1956.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."}],"balance_after":209650,"source":{"system":"sec-edgar","filing":"0000899243-19-019182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924319019182/doc4.xml","form_type":"4"}},{"id":3467249,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-07-03T20:32:42.000Z","date":"2019-07-01","kind":"sale","acquired":false,"shares":9200,"price":18.9764,"value":174582.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $18.52 to $19.28. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":209750,"source":{"system":"sec-edgar","filing":"0000899243-19-019182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924319019182/doc4.xml","form_type":"4"}},{"id":3499904,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-06-05T22:11:42.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":9300,"price":19.9025,"value":185093.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were sold in multiple transactions at per share prices ranging from $19.45 to $20.42.  The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":218950,"source":{"system":"sec-edgar","filing":"0000899243-19-015647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924319015647/doc4.xml","form_type":"4"}},{"id":3726132,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee stock option","published_at":"2018-12-18T22:27:17.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2019."}],"balance_after":74000,"derivative":{"exercise_price":24.28,"expiration_date":"2028-12-14","underlying":"Common Stock","underlying_shares":74000},"source":{"system":"sec-edgar","filing":"0000899243-18-031346","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924318031346/doc4.xml","form_type":"4"}},{"id":3979233,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":109847,"kind":"person","name":"Seymour Albert","position":1,"cik":"0001735324","reported_name":"Seymour Albert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee stock option","published_at":"2018-03-29T23:28:18.000Z","date":"2018-03-27","kind":"grant","acquired":true,"shares":66501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 equal monthly installments on the first day of each calendar month following March 27, 2018."}],"balance_after":66501,"derivative":{"exercise_price":16,"expiration_date":"2028-03-27","underlying":"Common Stock","underlying_shares":66501},"source":{"system":"sec-edgar","filing":"0000899243-18-008926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924318008926/doc4.xml","form_type":"4"}}]}